Following the advice of scientific authorities, the government is extending the administration of a second booster dose in an “epidemiological context which remains worrying”.
The government has decided to extend the administration of a second booster dose of the anti-Covid vaccine to pregnant women, to people under 60 years of age.at risk» and to those living in the entourage of fragile people.
Following the advice of the scientific authorities (Haute Autorité de Santé and Orientation Council for the Vaccine Strategy), it took this decision in a “epidemiological context which remains worrying, with highly contagious variants“Explained the Ministry of Health on Wednesday July 20.
SEE ALSO – Monkey pox: France extends vaccination to the most exposed categories
Five million people affected
The government has decided to extend the second recall “now to adults aged 18 to 60 identified as being at risk of a severe form of Covid, to pregnant women and to people living in the entourage of vulnerable or immunocompromised people“, he detailed in a press briefing. This extension concerns around five million people, which brings the number of French people eligible for this second booster dose to around 17 million. Until now, only those over 60 and immunocompromised people had access to it, or some 12 million eligible people. Of these, around 4 million received a second booster. This additional booster dose is possible from three months after the 1st booster for the most fragile (over 80 years old, nursing home residents, severely immunocompromised). For others, it can be administered six months after the first booster.
And “in case of infection between the first and the second booster, we can do a second booster shot three months after the infection“, said the Ministry of Health. Asked if the government planned to offer a second reminder to the general population in the fall, the ministry replied:clearly not“. “Today, there is no likely scenario that would extend the second recall to everyone, although we must remain cautious“, he said. He also delivered the figures for vaccinations with the vaccine from the American laboratory Novavax, based on classic technology. “We expected significant figures, this is not what we observed“, conceded the ministry. “Only 28,000 doses of this vaccine have been injected since March, it is very few but it remains a useful vaccine“, he judged.
SEE ALSO – Covid: “The government has no intention of releasing the pressure on the population”